info@tiba.bio
 

Media CoverageCEPI Assessing Advanced RNA Nanoparticle Vaccine

January 23, 2023

The partnership between CEPI and Tiba Biotech is the focus of this article in Science & Enterprise. Read more

previous
Next-Gen RNA Vaccine Technology Focuses on Disease X
next
Coup de pouce majeur pour les vaccins à ARNm ciblant la «maladie X»
https://i0.wp.com/tiba.bio/wp-content/uploads/2021/05/Tiba-small-logo2.png?fit=140%2C58&ssl=1
info@tiba.bio
1 Broadway, 14th Fl., Cambridge MA

Keep connected with us

Check out our careers page
See what we are doing!

© 2024 Tiba Biotech LLC. All rights reserved

Terms and Conditions